Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px
Document › Details

Merck KGaA. (1/28/11). "Press Release: Merck Appoints Frederic Wohlwend as CIO". Darmstadt.

Organisations Organisation Merck KGaA
  Group Merck (DE) (Group)
  Organisation 2 Serono S.A.
  Today Merck Serono International S.A.
  Group Merck (DE) (Group)
Products Product information services
  Product 2 pharmaceutical
Persons Person Wohlwend, Frédéric (Bertorelli Group 201905 Managing Partner at Forestay Capital before Merck (DE) + Serono)
  Person 2 Beckmann, Kai (Merck KGaA 201709– Executive Board Member for Performance Materisl before Human Resources)
     


Frederic Wohlwend will assume the duties of Chief Information Officer (CIO) of Merck KGaA on April 1, 2011, succeeding Kai Beckmann, who will join the Merck Executive Board with responsibility for global Human Resources on that date. Wohlwend will report directly to the Chairman of the Executive Board Dr. Karl-Ludwig Kley.

Wohlwend, 45, has been Senior Vice President Information Services for Merck's Chemicals business sector, which includes the Performance Materials and Merck Millipore divisions, since October 2010. During the previous three years, he served as Senior Vice President Information Services for Merck's Pharmaceuticals business sector, which includes the Merck Serono and Consumer Health Care divisions. He was highly involved in the IT integration activities following the acquisitions of Serono in 2007 as well as Millipore in 2010.
Wohlwend joined Merck in 2007 with the acquisition of the Swiss biotech pharmaceutical company Serono SA. He joined Serono in 1991 and held positions of increasing responsibility, lastly as CIO. He has a degree in Business Administration from HEC University in Geneva. A Swiss citizen, he is married and has two children.


All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to http://www.merck.de/subscribe to register online, change your selection or discontinue this service.

Merck is a global pharmaceutical and chemical company with total revenues of € 7.7 billion in 2009, a history that began in 1668, and a future shaped by approximately 40,000 (including Merck Millipore) employees in 64 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

   
Record changed: 2019-10-06

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

More documents for Merck (DE) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px




» top